ReviewInternational journal of molecular sciences2026
Stem Cells for Cultured Meat: Cell Sources, Lineage Specification, and Biomaterial Scaffolds for Edible Tissue Engineering.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cultured meat aims to manufacture genuine animal tissue from cells in vitro, displacing the environmental and ethical liabilities of livestock slaughter. Because the final product must reproduce the fibre architecture, fat marbling, and nutrition of conventional meat, the cell-its identity, proliferative ceiling, and differentiation fidelity-is the central determinant of feasibility. This review consolidates the stem cell biology of cultured meat from a tissue engineering perspective. We first compare the principal cell sources: muscle satellite cells, which offer authentic myogenicity but limited expansion; pluripotent stem cells, which are effectively immortal but require directed differentiation; and mesenchymal, adipogenic, and fibro-adipogenic progenitors that supply fat and connective tissue. We then examine how myogenic and adipogenic commitment is controlled through growth-factor and small-molecule signalling, serum-free medium design, and co-culture strategies that recreate the multicellular composition of meat. We next survey biomaterial scaffolds-edible microcarriers, hydrogels, and decellularized plant matrices-that organize stem cells into anisotropic, perfusable, macroscale constructs, drawing on scaffold-design principles from regenerative medicine. Finally, we address bioreactor scale-up, medium cost, cell-line stability, and regulatory translation. We argue that cultured meat will advance fastest when cell source, differentiation protocol, and scaffold architecture are co-designed rather than optimized in isolation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.